First Tracks Biotherapeutics Inc First Tracks Biotherapeutics Inc

First Tracks Biotherapeutics Inc

TRAX

Rank in Stocks #6530
First Tracks Biotherapeutics, Inc., situated in San Diego, California,... First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Share Price
$47.10
Last synced: 2026-11-13
Market Cap
$1.68B
Change (1 day)
-3.29%
Change (1 year)
-
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Trade First Tracks Biotherapeutics Inc (TRAX)

Category

Healthcare
EPS for First Tracks Biotherapeutics Inc (TRAX)
EPS as of September 2026 TTM: $-3.27
According to First Tracks Biotherapeutics Inc's latest financial reports, its current EPS (TTM) is $-3.27. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for First Tracks Biotherapeutics Inc from 2023 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-3.27 0.00%
2025 0.00 0.00%
2024 0.00 -100.00%
2023 $-3.05 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 -72.78%
US
$15.66 -578.90%
US
$-7.07 116.21%
US
$-5.29 61.77%
AU
$12.73 -489.36%
BE

Questions about First Tracks Biotherapeutics Inc's earnings per share (EPS)

What is First Tracks Biotherapeutics Inc's earnings per share (EPS)?

First Tracks Biotherapeutics Inc's earnings per share (EPS) over the last twelve months is $-3.27, as of Sep 2026.

What was First Tracks Biotherapeutics Inc's earnings per share (EPS) in 2025?

In 2025, First Tracks Biotherapeutics Inc's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.

How has First Tracks Biotherapeutics Inc's earnings per share (EPS) changed since 2023?

From 2023 to 2025, First Tracks Biotherapeutics Inc's earnings per share (EPS) was highest in 2025 (0.00) and lowest in 2023 ($-3.05).

How does First Tracks Biotherapeutics Inc's earnings per share (EPS) compare with similar companies?

First Tracks Biotherapeutics Inc's earnings per share (EPS) ($-3.27) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.